Literature DB >> 6884831

The significance of microscopic involvement of the parametrium and/or pelvic lymph nodes in cervical cancer stages IB and IIA.

O P Bleker, B W Ketting, B van Wayjen-Eecen, G J Kloosterman.   

Abstract

From 1961 through 1980, 388 patients with cervical carcinoma stage IB (272) and stage IIA (116) were treated by radical hysterectomy and pelvic lymphadenectomy. The operation specimens were divided into four groups: no involvement of the parametrium and pelvic lymph nodes (71.4%), involvement of the parametrium alone (7.2%), involvement of the pelvic lymph nodes alone (11.9%), and involvement of both the parametrium and pelvic lymph nodes (9.5%). Two hundred thirty-eight patients were followed for at least 5 years. The corrected 5-year survival figures for these four groups (stages IB and IIA together) were 90.3, 75.0, 62.1, and 50.0%, respectively. The differences are of statistical significance (P less than 0.005). Not only the stage of disease and involvement of the lymph nodes, but clearly also the involvement of the parametrium is of significance for the results of treatment in cervical cancer.

Entities:  

Mesh:

Year:  1983        PMID: 6884831     DOI: 10.1016/0090-8258(83)90009-4

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  6 in total

Review 1.  Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.

Authors:  Charles A Leath; Bradley J Monk
Journal:  Gynecol Oncol       Date:  2018-06-27       Impact factor: 5.482

2.  HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study.

Authors:  K Lukaszuk; J Liss; I Wozniak; W Sliwinski; J Emerich; C Wojcikowski
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

3.  Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study.

Authors:  Donald G Mitchell; Bradley Snyder; Fergus Coakley; Caroline Reinhold; Gillian Thomas; Marco A Amendola; Lawrence H Schwartz; Paula Woodward; Harpreet Pannu; Mostafa Atri; Hedvig Hricak
Journal:  Gynecol Oncol       Date:  2008-11-20       Impact factor: 5.482

4.  Pretreatment tumour-antigen Ta-4 in serum of patients with squamous cell carcinoma of the uterine cervix.

Authors:  G Kenter; J M Bonfrer; A P Heintz
Journal:  Br J Cancer       Date:  1987-08       Impact factor: 7.640

Review 5.  Barriers and Challenges to Treatment Alternatives for Early-Stage Cervical Cancer in Lower-Resource Settings.

Authors:  Emily S Wu; Jose Jeronimo; Sarah Feldman
Journal:  J Glob Oncol       Date:  2017-05-11

6.  Human Papillomavirus Status in Primary Lesions and Pelvic Lymph Nodes and Its Prognostic Value in Cervical Cancer Patients with Lymph Node Metastases.

Authors:  Peng Chen; Weiyuan Zhang; Dong Yang; Weiyang Zhang; Si Gao
Journal:  Med Sci Monit       Date:  2019-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.